Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
-6.23%
+0.24%
+79.52%
+0.11%
META
Meta Platforms
$750.90
Chart
$
$
$
$
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-6.23%
+0.24%
+79.52%
+0.11%
META
Meta Platforms
Current Price
$750.90
Login to view Meta Platforms (META) recommendation from the last 90 days from financial news and social media.
Chart
$
$
$
$
META has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Risks Indicators
Beta greater than 1.0
Investors losing confidence
META Latest Analysis
Meta Announces Quarterly Cash Dividend. ) board of directors today declared a quarterly cash dividend of ...
Thu Sep 11, 2025
Meta Announces Quarterly Cash Dividend. MENLO PARK Calif. Sept. 11 2025 /PRNewswire/ -- The Meta Platforms Inc. (Nasdaq: META) board of directors today declared a quarterly cash dividend of $0.525 per share of the companys outstanding Class A common stock and Class B common stock payable on September 29 2025 to...
Thu Sep 11, 2025
FTC launches inquiry into AI chatbots of Alphabet Meta and others.
Thu Sep 11, 2025
Silexion Therapeutics Shares Surge On Positive Preclinical Pancreatic Cancer Data. ) stock is trading higher on Thursday with a session volume of 16.87 million compared to the average volume of 74.2 thousand as per .The company released new preclinical data demonstrating that subcutaneously administered SIL204 successfully reaches all primary sites of pancreatic cancer metastasis and shows anti-tumor activity.The study evaluated SIL204’.s biodistribution and therapeutic activity following s
Thu Sep 11, 2025
Silexion Therapeutics Reports Positive Preclinical Data Demonstrating SIL204s Reach and Activity in Major Pancreatic Cancer Metastatic Sites Following Systemic Administration. New Positive Preclinical Data Shows Succesful Drug Distribution to Liver Peritoneum and Lung with Measurable Reductions in Tumor Burden at Clinically Relevant DosesResults Provide Further Validation of the Systemic Component of a Dual-Route Administration Strategy Enabeling Potential Targeting of Both Primary Tumors and Me
Thu Sep 11, 2025
San Francisco Probes Scale AI Over Labor Practices After $14 Billion Meta Deal Raising Questions On Gig Worker Rights In AI Boom: Report. San Francisco is investigating Scale AI'.s labor practices just months after ) bought nearly half of the artificial intelligence startup in a $14 billion deal casting new attention on how tech'.s fastest-growing firms treat the workers powering their models.The city'.s Office of Business Insider.The agency enforces local rules on minimum wage over
Thu Sep 11, 2025
2 No-Brainer Tech Stocks to Buy Right Now. Key PointsMeta Platforms is not messing around when it comes to advancing its AI capabilities.
Thu Sep 11, 2025
Olivan Javier sells Meta Platforms shares for $390k.
Wed Sep 10, 2025
A Closer Look at Meta Platformss Options Market Dynamics. Whales with a lot of money to spend have taken a noticeably bearish stance on Looking at options history for Meta Platforms (NASDAQ:) we detected 184 trades.If we consider the specifics of each trade it is accurate to state that 29% of the investors opened trades with ish expectations and 45% with bearish.From the overall spotted trades 50 are puts for a total amount of $3163108 and 134 calls for a total amount of $9055360.After evaluatin
Wed Sep 10, 2025
Basal Cell Neoplasms Clinical Trial Pipeline Accelerates as 22 Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight. Basal Cell Neoplasms Clinical Trial Pipeline Accelerates as 22 Pharma Companies Rigorously Develop Drugs for Market Entry |. DelveInsightBasal Cell Neoplasms are the most common type of skin cancer arising from basal cells in the epidermis and typically characterized by slow growth and low metastatic potential. The increasing prevalence of skin cancers due
Wed Sep 10, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
META Stock trends
META Stock performance
META Stock analysis
META investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Hover over the category for more information
Overview
Trending
Screener
Insights
Top Rated
Momentum
Earnings